The good news is that GLP-1 agonists by themselves lower blood sugar in a glucose-dependent way, they help your body release insulin only when sugar is high, so they carry a low risk of hypoglycemia
The arginate form, also known as the stable form, has been shown in studies from Diagen, the original patent holder of BPC 157, to remain stable in the stomach, which means more of it gets absorbed and becomes bioavailable
Can heart disease be reversed if you focus on plaque and artery congestion alone
One way to achieve a calorie deficit is to reduce your caloric intake
Men receiving care at our Kelowna clinic undergo a personalized evaluation to ensure oral BPC-157 supports their recovery, performance, and overall wellness plan
Scott Gulinson, M.D., FACOG delivers weight loss medicine that works with your biology, not against it